Search

everythinglearnresearchcommunity

for

Search:↓

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

The drug combination was safe and showed promise in treating advanced tumors.

Self-assembling peptide hydrogels effectively deliver drugs locally, enhancing treatment and reducing side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Brodalumab is more effective than ustekinumab in treating psoriasis.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.